APOE and dementia: Though further cohort studies explicitly aimed at testing the moderator effect of these risk factors are needed to draw robust conclusions, our results suggest that the impact of BMI and ApoE4 on dementia risk may be mediated via their effects on HPCs, further supporting the need for more individualised clinical trials.